Health Care: Drugs

Gilead Sciences Inc (GILD: NASDAQ)

$107.56 n/a | n/a%
08/29/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 11.20B 9.70B 8.39B 7.95B
Cost of Sales 2.51B 2.19B 1.82B 1.60B
Gross Operating Profit 8.69B 7.51B 6.56B 6.35B
Selling, General, and Administrative Expenses 1.70B 1.46B 1.24B 1.04B
Research & Development 2.12B 1.76B 1.23B 1.07B
Operating Income before D & A (EBITDA) 4.87B 4.29B 4.09B 4.23B
Depreciation & Amortization 344.70M 278.21M 302.23M 265.48M
Interest Income 0.00 0.00 66.58M 60.29M
Other Income - Net -8.89M -37.28M 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 4.52B 3.97B 3.86B 4.02B
Interest Expense 306.89M 360.92M 205.42M 108.96M
Pre-Tax Income 4.21B 3.61B 3.65B 3.91B
Income Taxes 1.15B 1.04B 861.94M 1.02B
Minority Interest -17.52M -17.97M -14.58M -11.51M
Net Income From Continuing Operations 3.06B 2.57B 2.79B 2.89B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 3.06B 2.57B 2.79B 2.89B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 3.07B 2.59B 2.80B 2.90B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
3.06B 2.57B 2.79B 2.89B
Preferred Dividends
Net Income Available To Common 3.06B 2.57B 2.79B 2.89B
Basic EPS from Continuing Ops. 2.01 1.71 1.81 1.69
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.01 1.71 1.81 1.69
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.01
Basic EPS, Total 2.01 1.71 1.81 1.70
Basic Normalized Net Income/Share 2.01 1.71 1.81 1.69
EPS fr Continuing Ops. 1.81 1.64 1.77 1.65
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.81 1.64 1.77 1.65
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.01
EPS, Total 1.81 1.64 1.78 1.66
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.81 1.64 1.77 1.65
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with GILD

Latest GILD Headlines from TheStreet

More Financial News for GILD

Press Releases for GILD

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter